Supply-chain overlap

direct ties · both sidesSources

direct ties · both sides

Only INAB 0

None

Shared 0

No disclosed counterparties: INAB.

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

Role chip = supplier or customerSource: SEC EDGAR

INABIN8BIO, Inc.

0.81−12.44%

Mkt cap$9.2MRevenue—Revenue—

AMGNAmgen Inc

462.39+0.46%

Regular sessionNov 6 '26

Mkt cap$249.0BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

vs

Compare

Regular sessionNov 6 '26

INABIN8BIO, Inc.

vs

AMGNAmgen Inc

0.81−12.44%

Price

462.39+0.46%

$9.2M

Mkt cap

$249.0B

—

Revenue

$10.4BQ3 FY26

—

Revenue

$36.8BFY25

INAB compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name